Meiji Yasuda Life Insurance Co acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the first quarter, Holdings Channel reports. The fund acquired 1,560 shares of the medical technology company’s stock, valued at approximately $302,000.
Several other hedge funds also recently made changes to their positions in the stock. Asset Planning Services Ltd. bought a new stake in shares of Teleflex during the first quarter valued at about $116,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Teleflex during the first quarter worth $155,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Teleflex by 14.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,267 shares of the medical technology company’s stock worth $213,000 after buying an additional 160 shares during the period. Mn Services Vermogensbeheer B.V. boosted its stake in shares of Teleflex by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,175 shares of the medical technology company’s stock worth $213,000 after buying an additional 35 shares during the period. Finally, Independence Advisors LLC acquired a new stake in shares of Teleflex during the first quarter worth $215,000. 93.02% of the stock is owned by institutional investors.
Shares of Teleflex Incorporated (NYSE:TFX) traded up 1.60% during trading on Friday, reaching $196.59. 163,506 shares of the company’s stock were exchanged. The company has a 50 day moving average of $198.07 and a 200 day moving average of $176.00. The firm has a market capitalization of $8.84 billion, a P/E ratio of 40.80 and a beta of 0.93. Teleflex Incorporated has a 52-week low of $136.53 and a 52-week high of $211.22.
Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 4th. The medical technology company reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.11. Teleflex had a net margin of 15.09% and a return on equity of 15.66%. The business had revenue of $487.90 million for the quarter, compared to analyst estimates of $472.81 million. During the same period last year, the business posted $1.52 EPS. Teleflex’s revenue was up 14.8% compared to the same quarter last year. Equities analysts anticipate that Teleflex Incorporated will post $8.16 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 15th. Shareholders of record on Monday, May 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Thursday, May 11th. This represents a $1.36 annualized dividend and a yield of 0.70%. Teleflex’s dividend payout ratio is 23.49%.
A number of analysts recently weighed in on TFX shares. Leerink Swann upped their price target on shares of Teleflex from $151.00 to $177.00 and gave the stock a “market perform” rating in a research report on Monday, February 13th. Stephens raised shares of Teleflex from an “equal weight” rating to an “overweight” rating in a research report on Friday, February 24th. Barclays PLC reaffirmed a “buy” rating and set a $205.00 price target on shares of Teleflex in a research report on Wednesday, March 1st. Needham & Company LLC started coverage on shares of Teleflex in a research report on Monday, March 6th. They set a “buy” rating and a $221.00 price target for the company. Finally, Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $217.00 price target for the company in a research report on Tuesday, March 14th. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $208.00.
In other Teleflex news, VP John Deren sold 2,246 shares of the firm’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $194.07, for a total value of $435,881.22. Following the sale, the vice president now directly owns 3,989 shares in the company, valued at approximately $774,145.23. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen K. M.D. Klasko sold 5,200 shares of the firm’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the completion of the sale, the director now owns 12,880 shares in the company, valued at $2,493,052.80. The disclosure for this sale can be found here. Company insiders own 2.15% of the company’s stock.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.